Research Article

The role of hyperuricemia in acute renal failure

Volume: 3 Number: 3 September 26, 2022
EN TR

The role of hyperuricemia in acute renal failure

Abstract

Objective: Acute renal failure is one of the most important factors affecting mortality in intensive care patients. The aim of this study was to elucidate whether there was a relationship between uric acid levels and/or acute kidney imjury/failıre (AKI). Material and Method: A total of 1000 individuals who were admitted to intensive care unit (ICU) of our institution without any prior renal disease and glomerular filtration rate (GFR) of 80-120 ml/minutes, have been enrolled in this retrospective analysis. The development of AKI in the ICU were evaluated via RIFLE criteria. In patients who developed AKI, it was checked whether there was an indication for renal replacement therapy (RRT). All patients in the ICU including the unconscious indivuduals and COVID-19 patients have been included in the analysis. Results: Acute renal failure (ARF) was observed in 27.1% (n=271) of the individuals. Hemodialysis had been administered in 44.3% (n=120) of patients with ARF. The reasons for hemodialysis were ischemia in 36%, sepsis and multifactorial reasons in 32% of the subjects. A statistically significant difference was found compared to the initial measurements in urea, creatinine, uric acid and sodium (Na) increased compared to baseline (p<0.001) as all parameters except potassium (K). All values from baseline increased at the time of diagnosis, while a decrease was observed in the GFR value (p<0.001). There was a statistically significant difference between the uric acid measurements of the patients undergoing hemodialysis (p<0.05) and uric acid measurements were increased compared to baseline. Conclusion: Regarding the results of this study one can conclude that serum uric acid level has been shown to be an independent risk factor for decreased renal function. Additionally, elevated uric acid levels lead to increased hemodialysis, morbidity and mortality in the ICU.

Keywords

Supporting Institution

yok

Project Number

yok

References

  1. Griffin BR, Liu KD, Teixeira JP. Critical care nephrology: core curriculum 2020. Am J Kidney Dis 2020; 75: 435-52
  2. Ostermann M, Zarbock A, Goldstein S, et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw Open 2020; 3: e2019209.
  3. Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric asid metabolism and excreation. Int J Cardiol 2015;S0167-5273 0342-9.
  4. Chaudhary K, Malhotra K, Sowers J, Aroor A. Uric acid-key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med 2013; 3: 208-20.
  5. Yildirim A, Altinkaynak K, Aksoy H, Sahin YN, Akcay F. Plasma xantine oxidase, superoxide dismutase and glutathione peroxidase activities and uric acid levels in severe and mild pre-eclampsia. Cell Biochem Funct 2004; 22: 213-7.
  6. Nan H, Dong Y, Gao W, Tuomilehto J, Qiao Q. Diabetes associated with a low serum uric acid level in a general Chinese population. Diabetes Res Clin Pract 2007; 76: 68-74.
  7. Jhonson RJ, Perez-Pozo SE, Sautin YY, et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev 2009; 30: 96-116.
  8. Şengül E, Binnetoğlu E, Yılmaz A. Kronik böbrek hastalarında serum ürik asit düzeyi ile glukoz, HbA1c, lipid profili, vücut kitle indeksi ve kan basıncı arasındaki ilişki. DEÜ Tıp Fakültesi Derg 2011; 25: 163-68.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

September 26, 2022

Submission Date

August 25, 2022

Acceptance Date

September 12, 2022

Published in Issue

Year 2022 Volume: 3 Number: 3

APA
Uysal, E., Seğmen, F., & Erdem, D. (2022). The role of hyperuricemia in acute renal failure. Journal of Medicine and Palliative Care, 3(3), 234-240. https://doi.org/10.47582/jompac.1166061
AMA
1.Uysal E, Seğmen F, Erdem D. The role of hyperuricemia in acute renal failure. J Med Palliat Care / JOMPAC / jompac. 2022;3(3):234-240. doi:10.47582/jompac.1166061
Chicago
Uysal, Elmas, Fatih Seğmen, and Deniz Erdem. 2022. “The Role of Hyperuricemia in Acute Renal Failure”. Journal of Medicine and Palliative Care 3 (3): 234-40. https://doi.org/10.47582/jompac.1166061.
EndNote
Uysal E, Seğmen F, Erdem D (September 1, 2022) The role of hyperuricemia in acute renal failure. Journal of Medicine and Palliative Care 3 3 234–240.
IEEE
[1]E. Uysal, F. Seğmen, and D. Erdem, “The role of hyperuricemia in acute renal failure”, J Med Palliat Care / JOMPAC / jompac, vol. 3, no. 3, pp. 234–240, Sept. 2022, doi: 10.47582/jompac.1166061.
ISNAD
Uysal, Elmas - Seğmen, Fatih - Erdem, Deniz. “The Role of Hyperuricemia in Acute Renal Failure”. Journal of Medicine and Palliative Care 3/3 (September 1, 2022): 234-240. https://doi.org/10.47582/jompac.1166061.
JAMA
1.Uysal E, Seğmen F, Erdem D. The role of hyperuricemia in acute renal failure. J Med Palliat Care / JOMPAC / jompac. 2022;3:234–240.
MLA
Uysal, Elmas, et al. “The Role of Hyperuricemia in Acute Renal Failure”. Journal of Medicine and Palliative Care, vol. 3, no. 3, Sept. 2022, pp. 234-40, doi:10.47582/jompac.1166061.
Vancouver
1.Elmas Uysal, Fatih Seğmen, Deniz Erdem. The role of hyperuricemia in acute renal failure. J Med Palliat Care / JOMPAC / jompac. 2022 Sep. 1;3(3):234-40. doi:10.47582/jompac.1166061

TR DİZİN ULAKBİM and International Indexes (1d)

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
 


 

download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiVHJfSW5kZXhfbG9nby5wbmciLCJwYXRoIjoiN2EzMC84NTVhL2UyMWMvNjlkZjRkZmVhNTUyNTYuNzg3NjU2ODgucG5nIiwiZXhwIjoxNzc2MjQ1Nzc0LCJub25jZSI6IjU0MDZkMWE2NmE1Y2QwZTJjNGYyNDA1OTM2MTE0YWIxIn0.Tt-WScFXTj5r2jji5eDMFApNzujLMjMPl8ivXRbozSI



f9ab67f.png
asos-index.png


 


download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiQ3Jvc3NyZWYuanBnIiwicGF0aCI6IjAzMzEvMTdkZi8yN2ZkLzY5ZGY0ZThhMDZkMjg0LjQxMjAyNDg5LmpwZyIsImV4cCI6MTc3NjI0NTkxNCwibm9uY2UiOiI2NjM1Yjc5MWFiY2I1MDQ0NjkzMTAxMDhjY2Y2NzRlMCJ9.5jDQBEY-KErkDK1QjDmv9ichOkNIn5CWYibe1Wz1644
icmje_1_orig.png
 
cc.logo.large.png
 
ncbi.png
 
google-scholar.pngpn6krf5.jpg
 


 

Our journal is in TR-Dizin, DRJI (Directory of Research Journals Indexing, General Impact Factor, Google Scholar, Researchgate, CrossRef (DOI), ROAD, ASOS Index, Turk Medline Index, Eurasian Scientific Journal Index (ESJI), and Turkiye Citation Index.

EBSCO, DOAJ, OAJI and ProQuest Index are in process of evaluation. 

 

Journal articles are evaluated as "Double-Blind Peer Review"